PROK
ProKidney Corp.
1.70$
+1.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.00 | -0.14 | -1.58 | -1.25 | -1.46 | -1.29 | -0.90 | |
| 0.00 | 0.01 | 0.06 | 0.05 | 0.06 | 0.06 | 0.05 | |
| 0.00 | 0.00 | 0.02 | 1.21 | 0.50 | 0.30 | 0.19 | |
| 0.01 | 0.00 | 0.02 | 1.21 | – | – | – | |
| 0.00 | 0.00 | 0.07 | -0.10 | 0.27 | 0.04 | 0.01 | |
| 0.00 | 0.03 | 0.16 | 0.03 | 0.55 | 0.30 | 0.11 | |
| 0.00 | -0.03 | -0.16 | -0.03 | -5.35 | 0.21 | 0.78 | |
| – | – | 0.00 | 8.82 | -0.15 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.11 | 2.24 | 8.91 | -0.15 | 1.47 | 0.19 | |
| 0.00 | -0.06 | 0.50 | 7.63 | -6.96 | 0.39 | 0.07 | |
| 0.00 | -0.16 | -1.74 | -1.28 | -2.01 | -1.59 | -1.01 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.